To confirm the above results, in a training cohort of HCC samples, we validated the expression of BOLA2, p62, Keap1, NRF2, and ATG4B and the proliferation marker (Ki-67) using immunohistochemistry (Figure 4A). This evidence concerns the gene KEAP1 and hepatocellular carcinoma.